Latest News

Browse by Company

  • All
  • AIkido Pharma
  • Aion Therapeutic
  • Albert Labs
  • Aleafia Health
  • Algernon Pharmaceuticals
  • Alphamind
  • Apex Labs
  • Atai Life Sciences
  • Atma Journeys
  • AWAKN
  • Beckley Psytech
  • Better Plant Sciences
  • BetterLife Pharma
  • Bexson Biomedical
  • Braxia Scientific
  • Bright Minds Biosciences
  • Brightmind
  • Buzz Capital
  • CaaMTech
  • CannaGlobal Wellness
  • CB Therapeutics
  • CBDV
  • Champignon Brands
  • Clearmind Medicine
  • Clerkenwell Health
  • Compass Pathways
  • Core One Labs
  • Cybin
  • Cybin Corp
  • Delic Corp
  • Delix Therapeutics
  • Delix Therapuetics
  • DemeRx
  • Diamond Therapeutics
  • Ehave
  • Ei Foundation
  • Ei Ventures
  • Eleusian Biosciences
  • Eleusis
  • Empower Clinics
  • Enosis Therapeutics
  • Entheon Biomedical
  • Entheos Foundation
  • Enveric Biosciences
  • Field Trip
  • Field Trip Health
  • Field Trip Health & Wellness
  • Filament Health
  • Fireside Project
  • GH Research
  • Gilgamesh Pharmaceuticals
  • GreenStar Biosciences
  • Havn Life
  • HAVN Life Sciences
  • Hollister Biosciences
  • Incannex Health
  • IntelGenx
  • Levitee Labs
  • Liberty Leaf
  • Lobe Sciences
  • Lusaris Therapeutics
  • MagicMed
  • MAPS
  • Mind Cure
  • MINDCURE
  • Mindleap
  • MindMed
  • MindMedicine
  • Mindset Pharma
  • Mota Ventures
  • Mycrodose Therapeutics
  • Mydecine
  • MYND Life Sciences
  • NeonMind
  • New Wave
  • NewLeaf Brands
  • Noetic Foundry
  • Nova Mentis
  • Nova Mentis Biotech
  • Novamind
  • Numinus
  • Nutritional High
  • NYU Langone Health
  • Octarine Bio
  • Optimi Health
  • Orthogonal Thinker
  • Osmond Labs
  • Osoyoos
  • Perception Neuroscience
  • Pharmadrug
  • Pharmather
  • Pilz Bioscience
  • PSFC
  • Psilera
  • Psilera Bioscience
  • PsyBio
  • PsyBio Therapeutics
  • Psyched Wellness
  • Psyence Group
  • Psygen
  • PSYK
  • Pure Extracts
  • Red Light Holland
  • Reset Pharma
  • Reunion Neuroscience
  • Revive Therapeutics
  • Seelos Therapeutics
  • Silo Pharma
  • Silo Wellness
  • Small Pharma
  • Sunstone Therapies
  • SYNTAC Institute
  • Synthesis Institute
  • Terran Biosciences
  • The Lundquist Institute
  • TheraPsil
  • Thoughtful Brands
  • Transcend Therapeutics
  • Tryp Therapeutics
  • Universal Ibogaine
  • Unlimited Sciences
  • Usona Institute
  • Wake Network
  • Wesana Health
  • Wuhan General Group
  • Yield Growth Corp
All
  • All
  • AIkido Pharma
  • Aion Therapeutic
  • Albert Labs
  • Aleafia Health
  • Algernon Pharmaceuticals
  • Alphamind
  • Apex Labs
  • Atai Life Sciences
  • Atma Journeys
  • AWAKN
  • Beckley Psytech
  • Better Plant Sciences
  • BetterLife Pharma
  • Bexson Biomedical
  • Braxia Scientific
  • Bright Minds Biosciences
  • Brightmind
  • Buzz Capital
  • CaaMTech
  • CannaGlobal Wellness
  • CB Therapeutics
  • CBDV
  • Champignon Brands
  • Clearmind Medicine
  • Clerkenwell Health
  • Compass Pathways
  • Core One Labs
  • Cybin
  • Cybin Corp
  • Delic Corp
  • Delix Therapeutics
  • Delix Therapuetics
  • DemeRx
  • Diamond Therapeutics
  • Ehave
  • Ei Foundation
  • Ei Ventures
  • Eleusian Biosciences
  • Eleusis
  • Empower Clinics
  • Enosis Therapeutics
  • Entheon Biomedical
  • Entheos Foundation
  • Enveric Biosciences
  • Field Trip
  • Field Trip Health
  • Field Trip Health & Wellness
  • Filament Health
  • Fireside Project
  • GH Research
  • Gilgamesh Pharmaceuticals
  • GreenStar Biosciences
  • Havn Life
  • HAVN Life Sciences
  • Hollister Biosciences
  • Incannex Health
  • IntelGenx
  • Levitee Labs
  • Liberty Leaf
  • Lobe Sciences
  • Lusaris Therapeutics
  • MagicMed
  • MAPS
  • Mind Cure
  • MINDCURE
  • Mindleap
  • MindMed
  • MindMedicine
  • Mindset Pharma
  • Mota Ventures
  • Mycrodose Therapeutics
  • Mydecine
  • MYND Life Sciences
  • NeonMind
  • New Wave
  • NewLeaf Brands
  • Noetic Foundry
  • Nova Mentis
  • Nova Mentis Biotech
  • Novamind
  • Numinus
  • Nutritional High
  • NYU Langone Health
  • Octarine Bio
  • Optimi Health
  • Orthogonal Thinker
  • Osmond Labs
  • Osoyoos
  • Perception Neuroscience
  • Pharmadrug
  • Pharmather
  • Pilz Bioscience
  • PSFC
  • Psilera
  • Psilera Bioscience
  • PsyBio
  • PsyBio Therapeutics
  • Psyched Wellness
  • Psyence Group
  • Psygen
  • PSYK
  • Pure Extracts
  • Red Light Holland
  • Reset Pharma
  • Reunion Neuroscience
  • Revive Therapeutics
  • Seelos Therapeutics
  • Silo Pharma
  • Silo Wellness
  • Small Pharma
  • Sunstone Therapies
  • SYNTAC Institute
  • Synthesis Institute
  • Terran Biosciences
  • The Lundquist Institute
  • TheraPsil
  • Thoughtful Brands
  • Transcend Therapeutics
  • Tryp Therapeutics
  • Universal Ibogaine
  • Unlimited Sciences
  • Usona Institute
  • Wake Network
  • Wesana Health
  • Wuhan General Group
  • Yield Growth Corp
Psychedelic Funding, Public Markets, and M&A in 2024
2024 Year in Review

Psychedelic Funding, Public Markets, and M&A in 2024

Ketamine on the Edge- Mindbloom’s At-Home Injections Spark Debate; UK Eyes Tougher Laws; DEA to Regulate Telehealth Prescribing; Spravato Sales Top $1bn
Analysis

Ketamine on the Edge: Mindbloom’s At-Home Injections Spark Debate; UK Eyes Tougher Laws; DEA to Regulate Telehealth Prescribing; Spravato Sales Top $1bn

Psychedelic Bulletin 187
Psychedelic Bulletin

Pα+ Psychedelic Bulletin #187: NYT Article Reignites MDMA Rejection Blame Game; FDA “Wanted to Approve” MDMA, MindMed Exec Says; GH’s Data and RFK Jr. Confirmation Send Psychedelics Stocks Soaring

GH Research Reports Strong Phase 2b Results for 5-MeO-DMT in Treatment-Resistant Depression
Analysis

GH Research Reports Strong Phase 2b Results for 5-MeO-DMT in Treatment-Resistant Depression

2025’s Psychedelic Policy Surge- A State-by-State, Bill-by-Bill Analysis
Analysis

2025’s Psychedelic Policy Surge: A State-by-State, Bill-by-Bill Analysis

PNF Archive ending dec 29 2024
Psychedelic News Feed Archive

The Psychedelic News Feed: September 2, 2024 – December 29, 2024

Q1'25- Psychedelic Drug Development Pipeline Updates
2024 Year in Review

Psychedelic Drug Development Pipeline Updates (Q1’25)

The Psychedelic Drug Development Pipeline- Bullseye Chart Q125
2024 Year in Review

Q1’25 Psychedelic Drug Development Pipeline: Bullseye Chart